[PDF][PDF] Betydelsen av Fluorodeoxyglukos Positron Emissions Tomografi (18F-FDG PET) för att detektera Alzheimer´ s sjukdom

T Franzén, J Sundqvist - 2021 - diva-portal.org
Betydelsen av Fluorodeoxyglukos Positron Emissions Tomografi (18F-FDG PET) för att
detektera Alzheimers sjukdom Importance of Page 1 Betydelsen av Fluorodeoxyglukos …

[18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia

JM Hoffman, BH Guze, LR Baxter, JC Mazziotta… - European …, 1989 - karger.com
Alzheimer's disease (AD) is becoming an increasingly important public health problem. The
clinical diagnosis of AD continues to be problematic and costly.[18 F]-fluorodeoxyglucose …

Positron emission tomography diagnosis of Alzheimer's disease

RE Coleman - PET clinics, 2007 - Elsevier
Positron emission tomography (PET) imaging of [18F]-2-fluoro-2-deoxy-D-glucose (FDG) is
accurate in the early detection of Alzheimer's disease (AD) and in the differentiation of AD …

Alzheimer disease: operating characteristics of PET—a meta-analysis

MB Patwardhan, DC McCrory, DB Matchar, GP Samsa… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To assess the operating characteristics of positron emission tomography (PET)
by using fluorine 18 fluorodeoxyglucose (FDG) in the diagnosis of Alzheimer disease …

[引用][C] [18F] Fluorodeoxyglucose Positron Emission Tomography in Alzheimer Disease and Related Disorders

N Miyazawa, T Shinohara - Positron Emission Tomography-Current …, 2012 - intechopen.com
The numbers of cases of Alzheimer disease (AD) and related disorders have been
increasing with higher life expectancy worldwide. In particular, the incidence has sharply …

Management impact of FDG-PET in dementia: results from a tertiary center memory clinic

A Elias, M Woodward, CC Rowe - Journal of Alzheimer's …, 2014 - content.iospress.com
Background: 2-[18F] fluoro-2-Deoxy-D-glucose (FDG) positron emission tomography (PET)
may assist the diagnosis of dementia but it is an expensive investigation. Objective: To …

Leading role of 18F-FDG-PET imaging in early diagnosis of Alzheimer's disease: an overview

E Cason, G Treglia, G Fagioli - Research and Reports in Nuclear …, 2011 - Taylor & Francis
Early detection of Alzheimer's disease (AD) is important to reveal preclinical pathological
alterations, to monitor disease progression, and to evaluate response to therapy. The study …

[HTML][HTML] Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study

PK Panegyres, JM Rogers, M McCarthy, A Campbell… - BMC neurology, 2009 - Springer
Background The aim of this study was to evaluate the diagnostic accuracy of positron
emission tomography (PET) using F 18 fluorodeoxyglucose (FDG) in the differential …

Improving 18F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer′ s Disease Studies

K Knešaurek - World journal of nuclear medicine, 2015 - thieme-connect.com
The goal was to improve Alzheimer′ s 2-deoxy-2-18 F-fluoro-D-glucose (18 F FDG)-
positron emission tomography (PET)/computed tomography (CT) imaging through …

Clinical 18F-FDG and amyloid brain positron emission tomography/CT in the investigation of cognitive impairment: where are we now?

M Dumba, S Khan, N Patel, L Perry… - The British Journal of …, 2019 - academic.oup.com
The number of people living with dementia is increasing, but as yet there remains no cure or
disease-modifying treatment. This review aims to help readers understand the role of 18F …